Professionals involved within the UK’s National Health Service (NHS) have revealed how they think about innovation in the NHS and what considerations are critical in making technology deployment ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the expanded use of Onward Medical’s ARC-EX System.

Philips has rolled out an AI-driven tool, DeviceGuide, intended to support clinicians during intricate cardiac interventions.

Durability, biocompatibility, and safety in orthopaedic, dental, and cardiovascular applications is essential. Read more here: ...

The dictates of the in vitro diagnostic regulation (IVDR) and “bureaucratic” issues are dampening the industry’s innovation aims.

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is beginning draw attention to the minimally invasive neurosurgical devices market ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to Simens shareholders. The company, whose stake had stood at 67%, will hand ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) drug delivery.

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology.

Boston Scientific has entered an agreement with Siemens Healthineers to push forward commercialisation activities for the latter’s AcuNav 4D ICE catheter.

The US FDA has granted 510(k) clearance, expanding the label of BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) system.

Beacon Platform combines EEG data with AI to produce quantitative brain function biomarkers through sleep analysis. Credit: mayam_studio / Shutterstock.com. Neurotechnology company Beacon Biosignals ...